Cuffed Versus Uncuffed Tracheal Tubes in PICU (PICU-BG-TT Study)
PICU-BG-TT
Ventilator Associated Complications in Neonate and Small Infant Undergoing Cardiac Surgery Using Cuffed and Uncuffed Tracheal Tubes. The PICU-BG-TT Study
1 other identifier
observational
242
1 country
1
Brief Summary
The CDC definition was used to identify patients with VAP and VAT. The CDC definition of VAP for infants \< 1 y.o. and children \> 1 or \< 12 y.o. are based on clinical and X-ray criteria. The CDC definition of Tracheitis are based on absence of clinical and radiographic evidence of pneumonia and the following criteria: positive culture obtained by deep tracheal aspirate and 2 signs of symptoms with no recognizable cause \[such as fever (\>38.5°C), cough, new or increased sputum production, rhonchi, or wheezing\]. The new CDC definition is used to identify patients with VAC and IVAC. The new definitions includes all associated complications (infection included) related to mechanical ventilation and exclude X-ray criteria. VAP, VAT, VAC, IVAC rate, expressed as the number of VAP/VAT/VAC/IVAC episodes per 1000 mechanical ventilator days (VAP/1000 MV days), were calculated for phase 1 and phase 2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 1, 2017
CompletedFirst Posted
Study publicly available on registry
April 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedAugust 3, 2023
August 1, 2023
2.2 years
March 1, 2017
August 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence rate difference of VAP and VAT between microcuffed TTs and uncuffed TTs
The incidence rate difference of VAP and VAT between microcuffed TTs and uncuffed TTs
At PICU discharge, an average of 2 weeks
Secondary Outcomes (5)
The incidence rate difference of VAC and IVAC
At PICU discharge, an average of 2 weeks
The reintubation rates for leakage
At PICU discharge, an average of 2 weeks
The post-extubation airway morbidity (post-extubation stridor)
At PICU discharge, an average of 2 weeks
The duration of intubation
At PICU discharge, an average of 2 weeks
The length of PICU stay
At PICU discharge, an average of 2 weeks
Study Arms (2)
Patients intubated with uncuffed tracheal tubes
Portex uncuffed TT sizes selected according to local institutional guidelines. Tracheal intubation performed under direct laryngoscopy by the oral or nasal route, without or with the use of bougies or stylets. TT insertion depth managed according to institutional guidelines in uncuffed TTs.
Patients intubated with cuffed tracheal tubes
Cuffed TT sizes selected as follows: ID 3.0 mm for birth (\>3 kg body weight) to \< 8 months; ID 3.5 mm for 8 to \< 12 months (Salgo, Schmitz et al. 2006). Tracheal intubation performed under direct laryngoscopy by the oral or nasal route, without or with the use of bougies or stylets. TT insertion depth managed according to the depth marking in cuffed TTs.
Interventions
Cuffed tracheal tube with an anatomically designed high volume - low pressure tube cuff, with a recommendation chart for tube size selection available for pediatric anesthesia
Eligibility Criteria
Pediatric patient in need intubation for cardiac surgery and transferred to the PICU.
You may qualify if:
- Neonates \>35/40 gestation;
- Expected to require ventilation for \> 24 hours;
- Age: 0 - 5 year.
You may not qualify if:
- Parents refused consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pediatric intensive care unit - ASST Papa Giovanni XXIII
Bergamo, BG, 24127, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Mirco Nacoti, MD
ASST Papa Giovanni XXIII di Bergamo
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2017
First Posted
April 26, 2017
Study Start
January 1, 2017
Primary Completion
March 8, 2019
Study Completion
June 30, 2019
Last Updated
August 3, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share